Topic
oncology
26 stories related to this topic, newest first.
wattsupwiththat.comworld13 hrs ago
50 Million Americans Live in Counties Without Radiation Oncology Sites
An analysis of radiation oncology practice sites from 2018 to 2025 found that more than 50 million Americans now reside in counties without such facilities. Losses were concentrated in rural areas and among independent centers.
news.sky.comworld5 days ago
Study Finds 40 Percent of Ovarian Cancer Cases Diagnosed After Emergency Room Admission
@ABC reported that a BMJ Oncology study published Tuesday found 40% of women with ovarian cancer are diagnosed following emergency room visits. Patients diagnosed this way are three times less likely to catch the disease at an early stage. The analysis examined registry data for…
AB
New York Postpolitics26 days ago
Medical Director Highlights Education Access as Equalizer for Innovation
John Shen, Medical Director of Oncology and Tertiary Care at Heritage Provider Network, stated that access to education serves as the great equalizer. The comment came during remarks linking equal educational opportunity to both the American dream and continued technological prog…
Nprscience34 days ago
GLP-1 Drugs Linked to Lower Cancer Risk in Observational Studies, but Causation Unproven
Analyses presented at the May 2026 American Society of Clinical Oncology meeting found reduced cancer incidence and progression among patients taking GLP-1 obesity treatments.
benzinga.comworld34 days ago
GSK to Reverse Oncology Exit With Largest Acquisition in Eight Years
The company is buying a cancer-focused business in its biggest deal since 2018, reversing an earlier decision to exit the field.
MA
finance.yahoo.comfinance35 days ago
Analysts Raise Targets on Oncology Institute and Victoria's Secret, Cut Guidewire Software
BTIG lifted its Oncology Institute price target to $8. JP Morgan raised Victoria's Secret to $88 while DA Davidson trimmed Guidewire to $222.
Statscience38 days ago
Patient Reports Benefit from Revolution Medicines’ Daraxonrasib as Oncologists Applaud Data but Biotech Stocks Fall
Leanna Stokes, diagnosed with metastatic pancreatic cancer in 2023, discussed her experience in a Revolution Medicines clinical trial on a June 4, 2026 podcast. Oncologists gave a standing ovation to data on the company’s drug daraxonrasib presented at last week’s American Societ…
Fox Newsscience41 days ago
Study Finds Four-Week Yoga Program Reduced Insomnia and Fatigue in Cancer Survivors
A randomized trial of 410 cancer survivors found that twice-weekly yoga sessions produced moderate-to-large reductions in mood disturbance and fatigue. The study was presented at the 2026 American Society of Clinical Oncology Annual Meeting.
Nbc Newsworld42 days ago
Personalized mRNA Vaccine Shows Reduced Melanoma Recurrence in Small Phase 2 Trial
A Moderna and Merck experimental vaccine cut melanoma recurrence risk by half in a five-year trial. Results were presented June 1, 2026, at the American Society of Clinical Oncology meeting.
benzinga.comscience43 days ago
Ivonescimab Shows 34% Reduction in Death Risk vs. Standard Therapy in China-Only Squamous NSCLC Trial
Data from a China-only trial of ivonescimab were presented May 31, 2026, at the American Society of Clinical Oncology meeting in Chicago and published simultaneously in The Lancet.
Statscience44 days ago
BioNTech and Pfizer Present Bispecific Antibody Data at Oncology Meeting
BioNTech and Pfizer presented data on bispecific antibodies at the American Society of Clinical Oncology annual meeting. The companies highlighted results from studies involving new immunotherapies. Coverage also noted comments from an FDA official on agency operations.
The Guardianscience44 days ago
Amivantamab Shows Tumor Responses in 43 of 102 Patients with Advanced Head and Neck Cancer
An international trial found the Johnson & Johnson drug shrank or eliminated tumors in 43 of 102 patients whose disease had resisted prior chemotherapy and immunotherapy. Results will be presented Sunday at the American Society of Clinical Oncology meeting in Chicago.
Statscience44 days ago
Rick Pazdur: FDA Turmoil Creates Opportunity to Rebuild Agency with Industry and Academic Talent
Former top oncology regulator Rick Pazdur told a STAT audience in Chicago that recent political appointees caused substantial destruction at the FDA and that new leadership should rebuild rather than restore the prior structure.
prnewswire.comscience44 days ago
Galleri Blood Test Shows No Significant Reduction in Advanced Cancers but Cuts Stage 4 Diagnoses by 14% in Large NHS Trial
A multi-cancer early detection blood test did not reduce late-stage diagnoses when added to standard screening. Data were presented at the American Society of Clinical Oncology meeting in Chicago.
thehindu.comscience52 days ago
Merck drug combination reduces lung cancer progression risk in trial
A Merck antibody-drug conjugate combined with Keytruda lowered the risk of tumor progression by 65 percent in a Phase 3 lung cancer study. The results come from an abstract released ahead of the American Society of Clinical Oncology meeting.
manilatimes.netfinance53 days ago
Perspective Therapeutics to Present Clinical Updates at 2026 ASCO Meeting
Perspective Therapeutics announced it will present data from three ongoing cancer treatment studies at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago from May 29 to June 2.
forbes.comworld61 days ago
Startup Develops System To Track Cancer Treatment Response In Real Time
A startup valued at $250 million has created technology that monitors how tumors respond to cancer treatments as they occur. The system aims to provide physicians with immediate data on treatment effectiveness rather than waiting for traditional scans. Forbes reported the develop…
FO
Benzingascience62 days ago
Bristol Myers Squibb Agrees to Up to $15.2B Deal With Hengrui Pharma for 13 Early-Stage Programs
The deal covers 13 early-stage programs in oncology, hematology and immunology. Bristol Myers Squibb will pay up to $950 million in near-term payments while gaining rights to several drug candidates outside China.
forbes.comai67 days ago
Immunai Expands Oncology Collaboration With AstraZeneca
The New York-headquartered, Israeli-founded AI biotech company Immunai has expanded its multi-year collaboration with AstraZeneca in oncology clinical development. Under the agreement, Immunai is eligible to receive up to $37.5 million over 2026 and 2027. The companies will conti…
JE
medpagetoday.comscience70 days ago
GLP-1 Obesity Drugs Generate Higher R&D Returns Than Oncology
Obesity treatments have become the leading driver of pharmaceutical research and development gains, surpassing oncology. A Deloitte partner highlighted concentration risks for companies reliant on these drugs. Plus-size model Ashley Graham described the trend as disheartening for…
The Timesscience75 days ago
AstraZeneca Reports Higher-Than-Expected First-Quarter Revenue and Profit
AstraZeneca announced an 8 percent increase in first-quarter revenue to $15.29 billion, exceeding analyst forecasts. The growth was driven by oncology and rare disease segments. The company reaffirmed its full-year outlook for revenue and earnings growth.
Substrate placeholder — needs reviewworld84 days ago
South Korea Approves Over 50 Clinical Trials in First Quarter
South Korea approved 53 clinical trials in the first quarter of 2026, with most led by overseas entities. Data from the Korea Biomedicine Industry Association indicates a focus on antibody-based drugs and oncology. An association official stated that this reflects the country's r…
Substrate placeholder — needs reviewscience97 days ago
Tumor Mutations Often Unidentified, Limiting Use of Advanced Targeted Therapies
Many advanced targeted therapies remain unused because mutations in tumors are not identified through testing. According to STAT News, this gap affects patient treatment options in oncology. The issue highlights challenges in precision medicine implementation.
ST
Substrate placeholder — needs reviewworld97 days ago
Oncoclinicas Considers Emergency Creditor Protection Amid Financial Pressures
Brazilian oncology provider Oncoclinicas is evaluating a request for emergency protection from creditors due to mounting financial challenges, sources told @business. The company operates a network of cancer treatment centers across Latin America. This move would aim to restructu…
BU
Substrate placeholder — needs reviewscience97 days ago
Gilead Sciences Acquires German Biotech Tubulis for Over $3 Billion
Gilead Sciences announced the acquisition of Tubulis, a German biotechnology company, for more than $3 billion. The deal aims to expand Gilead's oncology drug development pipeline. Tubulis specializes in antibody-drug conjugates for cancer treatments.
ST
Substrate placeholder — needs reviewscience98 days ago
Oncologist Reflects on Admitting Uncertainty in Patient Care Over 25 Years
An oncologist with 25 years of experience discusses the challenges of addressing patient questions amid medical uncertainties. The article highlights advancements in medicine, such as HIV treatment and stroke interventions, while noting the persistence of unpredictable outcomes i…